1165 related articles for article (PubMed ID: 18496141)
1. Paget cells in the esophagus: assessment of their histopathologic features and near-universal association with underlying esophageal adenocarcinoma.
Abraham SC; Wang H; Wang KK; Wu TT
Am J Surg Pathol; 2008 Jul; 32(7):1068-74. PubMed ID: 18496141
[TBL] [Abstract][Full Text] [Related]
2. Expression of beta-catenin, alpha-catenin, and E-cadherin in Barrett's esophagus and esophageal adenocarcinomas.
Washington K; Chiappori A; Hamilton K; Shyr Y; Blanke C; Johnson D; Sawyers J; Beauchamp D
Mod Pathol; 1998 Sep; 11(9):805-13. PubMed ID: 9758359
[TBL] [Abstract][Full Text] [Related]
3. Perianal Paget's disease: distinguishing primary and secondary lesions using immunohistochemical studies including gross cystic disease fluid protein-15 and cytokeratin 20 expression.
Nowak MA; Guerriere-Kovach P; Pathan A; Campbell TE; Deppisch LM
Arch Pathol Lab Med; 1998 Dec; 122(12):1077-81. PubMed ID: 9870855
[TBL] [Abstract][Full Text] [Related]
4. Muscularis mucosae duplication and the musculo-fibrous anomaly in endoscopic mucosal resections for barrett esophagus: implications for staging of adenocarcinoma.
Lewis JT; Wang KK; Abraham SC
Am J Surg Pathol; 2008 Apr; 32(4):566-71. PubMed ID: 18300796
[TBL] [Abstract][Full Text] [Related]
5. Expression of p53-related protein p63 in the gastrointestinal tract and in esophageal metaplastic and neoplastic disorders.
Glickman JN; Yang A; Shahsafaei A; McKeon F; Odze RD
Hum Pathol; 2001 Nov; 32(11):1157-65. PubMed ID: 11727253
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and prognostic significance of neuroendocrine cells in esophageal adenocarcinoma.
Hamilton K; Chiappori A; Olson S; Sawyers J; Johnson D; Washington K
Mod Pathol; 2000 May; 13(5):475-81. PubMed ID: 10824917
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor and basic fibroblast growth factor expression in esophageal adenocarcinoma and Barrett esophagus.
Lord RV; Park JM; Wickramasinghe K; DeMeester SR; Oberg S; Salonga D; Singer J; Peters JH; Danenberg KD; Demeester TR; Danenberg PV
J Thorac Cardiovasc Surg; 2003 Feb; 125(2):246-53. PubMed ID: 12579092
[TBL] [Abstract][Full Text] [Related]
8. Esophageal polypoid dysplasia of gastric foveolar phenotype with focal intramucosal carcinoma associated with Barrett's esophagus.
Asthana N; Mandich D; Ligato S
Am J Surg Pathol; 2008 Oct; 32(10):1581-5. PubMed ID: 18724240
[TBL] [Abstract][Full Text] [Related]
9. Duplication of the muscularis mucosae in Barrett esophagus: an underrecognized feature and its implication for staging of adenocarcinoma.
Abraham SC; Krasinskas AM; Correa AM; Hofstetter WL; Ajani JA; Swisher SG; Wu TT
Am J Surg Pathol; 2007 Nov; 31(11):1719-25. PubMed ID: 18059229
[TBL] [Abstract][Full Text] [Related]
10. E-cadherin expression in gastroesophageal reflux disease, Barrett's esophagus, and esophageal adenocarcinoma: an immunohistochemical and immunoblot study.
Swami S; Kumble S; Triadafilopoulos G
Am J Gastroenterol; 1995 Oct; 90(10):1808-13. PubMed ID: 7572899
[TBL] [Abstract][Full Text] [Related]
11. [Squamous carcinoma of the esophagus with extensive pagetoid dissemination].
Suárez Vilela D; Izquierdo García F; Alonso Orcajo N
Gastroenterol Hepatol; 1997; 20(7):360-2. PubMed ID: 9377235
[TBL] [Abstract][Full Text] [Related]
12. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience.
Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I
Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526
[TBL] [Abstract][Full Text] [Related]
13. Suppression of apoptosis does not foster neoplastic growth in Barrett's esophagus.
Soslow RA; Remotti H; Baergen RN; Altorki NK
Mod Pathol; 1999 Mar; 12(3):239-50. PubMed ID: 10102608
[TBL] [Abstract][Full Text] [Related]
14. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.
Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I
Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948
[TBL] [Abstract][Full Text] [Related]
15. Small adenocarcinomas of the esophagogastric junction: association with intestinal metaplasia and dysplasia.
Cameron AJ; Souto EO; Smyrk TC
Am J Gastroenterol; 2002 Jun; 97(6):1375-80. PubMed ID: 12094853
[TBL] [Abstract][Full Text] [Related]
16. Altered cadherin and catenin complexes in the Barrett's esophagus-dysplasia-adenocarcinoma sequence: correlation with disease progression and dedifferentiation.
Bailey T; Biddlestone L; Shepherd N; Barr H; Warner P; Jankowski J
Am J Pathol; 1998 Jan; 152(1):135-44. PubMed ID: 9422531
[TBL] [Abstract][Full Text] [Related]
17. Mucin core polypeptide expression in the progression of neoplasia in Barrett's esophagus.
Glickman JN; Blount PL; Sanchez CA; Cowan DS; Wongsurawat VJ; Reid BJ; Odze RD
Hum Pathol; 2006 Oct; 37(10):1304-15. PubMed ID: 16949933
[TBL] [Abstract][Full Text] [Related]
18. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
Wang KL; Wu TT; Choi IS; Wang H; Resetkova E; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Albarracin CT
Cancer; 2007 Feb; 109(4):658-67. PubMed ID: 17211865
[TBL] [Abstract][Full Text] [Related]
19. Clinical and endoscopic factors predict higher pathologic grades of Barrett dysplasia.
Anandasabapathy S; Jhamb J; Davila M; Wei C; Morris J; Bresalier R
Cancer; 2007 Feb; 109(4):668-74. PubMed ID: 17211862
[TBL] [Abstract][Full Text] [Related]
20. Diffuse pagetoid squamous cell carcinoma in situ of the esophagus: a case report.
Chu P; Stagias J; West AB; Traube M
Cancer; 1997 May; 79(10):1865-70. PubMed ID: 9149010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]